Senior insider sale
Chief Financial Officer at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$410.4K
21.66K shares
What this filing means
VAN HOUTE HANS plans to sell 21.66K shares of NURIX THERAPEUTICS, INC. valued at approximately $410.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001950047-26-007637
Officer· Chief Financial Officer
Since Jul 2020
21.66K
Shares to sell
$410.4K
Approx. market value
4.76K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
7/30/2026
4.76KTotal acquired4.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/30/2026 | Restricted Stock Units N/A | 4.76K | — |
| Total | 4.76K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.85K
Market value
$66.5K
7/30/2026
—Completed
Units to sell
14.05K
Market value
$233.3K
5/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.76K
Market value
$110.6K
8/4/2026
Total
Units
21.66K
Value
$410.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/30/2026 | 2.85K | $66.5K | — | Completed |
5/5/2026 | 14.05K | $233.3K | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 4.76K | $110.6K | NASDAQ | Planned |
| Total | 21.66K | $410.4K | ||